INNOVATION

FDA Approves ApneaRx – A New Treatment for Sleep Apnea

Apnea Sciences Corporation, announced that their breakthrough product ApneaRx was just approved by the FDA and is now available for the 20 million sleep apnea sufferers in America who think CPAP (continuous positive airway pressure mask pictured at right) is the only remedy for their disorder.

LAGUNA HILLS, CA – April 5, 2012 – Apnea Sciences Corporation announced that their breakthrough product ApneaRx was just approved by the FDA and is now available for the 20 million sleep apnea sufferers in America who think CPAP (continuous positive airway pressure mask pictured at right) is the only remedy for their disorder.

Fallon said, “Up until now there has not been an affordable “transition” oral appliance that has been good enough to help the medical practitioner decide whether an oral appliance, or CPAP therapy is best for their patients. Our research indicates that effective oral appliance therapy would be preferred by most patients.” What makes ApneaRx unique is that it does this without any moving parts, screws, metal rods or plastic bands used by much more expensive devices, or metal hardware that could compromise the patient.

ApneaRx will help the practitioner decide which treatment is best for their patient – custom oral appliance or CPAP. Oral appliance users are more compliant and CPAP therapy is more effective. Both therapies are successful 50-60 percent of the time and cost thousands of dollars. ApneaRx can reduce the cost risks associated with these therapies. It can be adjusted just like the more expensive custom oral appliances at a fraction of the cost to help determine clinical efficacy of oral appliances. If the ApneaRx treatment is successful, a more customized oral appliance can be prescribed. If not, CPAP should be used. Continued usage of ApneaRx is also a good economic alternative.

Patrick Wolcott, MD, Medical Director of The Sleep Center of Southern California in Encinitas, California commented that “ApneaRx provides the sleep clinician with an inexpensive way to determine the best treatment for their patients. In my practice, oral appliance therapy often leads to better compliance and a happier patient.”

Ed Spiegel, DDS, a prominent dentist specializing in sleep medicine in Scottsdale Arizona who lectures nationally, stated that “ApneaRx is a great advancement and will help give patients more piece of mind when choosing custom oral appliance therapy to reduce their sleep apnea.”

Fallon commented, “The reception for ApneaRx has been overwhelming. The need for a “transition” oral appliance to help determine the best and most cost effective sleep apnea treatment is being driven by industry trends to contain health costs.”

Dr. Wolcott believes ApneaRx will be well received by the sleep apnea medical community.